𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Summary of ‘Interventions for bone disease in children with chronic kidney disease’

✍ Scribed by Evidence-Based Child Health Editorial Office

Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
42 KB
Volume
6
Category
Article
ISSN
1557-6272

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The benefit of renal artery stenting in
The benefit of renal artery stenting in patients with atheromatous renovascular disease and advanced chronic kidney disease
✍ Philip A. Kalra; Constantina Chrysochou; Darren Green; Ching M. Cheung; Kaivan K 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 2 views

## Abstract **Background**: Around 16% of all patients who present with atheromatous renovascular disease (ARVD) in the United States undergo revascularization. Historically, patients with advanced chronic kidney disease (CKD) have been considered least likely to show improvement in renal functiona

FDA report: Ferumoxytol for intravenous
FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease
✍ Min Lu; Martin H. Cohen; Dwaine Rieves; Richard Pazdur 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

## Abstract On June 30, 2009, the United States Food and Drug Administration (FDA) approved ferumoxytol (Feraheme™ injection, AMAG Pharmaceuticals), an iron‐containing product for intravenous (IV) administration, for the treatment of iron deficiency anemia in adult patients with chronic kidney dise